Excerpt from Pulmonic Valvular StenosisSynonyms, Key Words, and Related Terms: pulmonary valvular stenosis, pulmonary valve stenosis, PVS, pulmonary stenosis, valvular, subvalvular, supravalvular, lesions, right ventricular outflow obstruction, Laurence-Moon-Biedl syndrome, Noonan syndrome, trisomy 21, cardiac malformations Please click here to view the full topic text: Pulmonic Valvular StenosisBackgroundUntil the 1950s, isolated pulmonary stenosis was considered to be a rare congenital abnormality.1 A review of the literature in 1949 yielded just 68 cases. However, as physiologic testing has improved, this condition has been more frequently recognized. Pulmonary valve stenosis (PVS) is described as those lesions that collectively are associated with obstruction to right ventricular outflow. PVS may be valvular, subvalvular, or supravalvular. PVS is the cause of isolated right ventricular outflow obstruction in 80% of cases.2 PathophysiologyThe pulmonic valve develops between the 6th and 9th week of gestation. Normally, the pulmonic valve is formed from 3 swellings of subendocardial tissue called the semilunar valves. These tubercles develop around the orifice of the pulmonary tree. The swellings are normally hollowed out and reshaped to form the 3 thin-walled cusps of the pulmonary valve. Failure to develop normally can result in the following malformations: fusion of 2 of the cusps, 3 leaflets that are thickened and partially fused at the commissures, or a single cone-shaped valve. In Noonan syndrome, tissue pads within the sinuses interfere with the normal mobility and function of the valve. The most common pathology is valvular pulmonic stenosis, which accounts for more than 80% of cases of pulmonary stenosis. Most cases are isolated valvular conditions, but they may be associated with a ventricular septal defect or secondarily lead to right ventricular infundibular hypertrophy.3 Isolated infundibular or subvalvular pulmonic stenosis is less common and is usually associated with a ventricular septal defect. Most cases are congenital and sporadic. PVS is not understood to have significant inheritance, but its concordance among siblings is higher than would be expected. Rarely, pulmonic stenosis is associated with recessively transmitted conditions such as Laurence-Moon-Biedl syndrome. Isolated pulmonic stenosis has been reported in association with trisomy 21, and infundibular stenosis has been associated with trisomy 18, 15, and 13. In patients with Noonan syndrome, pulmonic stenosis, classically with dysplastic valves, can be present. Additionally, in the congenital rubella syndrome, supravalvular pulmonic and pulmonary artery branch stenoses are frequently present. Acquired valvular disease is rare. The two most common etiologies are carcinoid and rheumatic fever. FrequencyUnited StatesPVS accounts for 10% of cases of congenital heart disease. Prevalence of pulmonary stenosis is 8-12% of all congenital heart defects. Isolated PVS with intact ventricular septum is the second most common congenital cardiac defect. PVS may occur in as many as 30% of all patients with congenital heart disease when associated with other congenital cardiac lesions. Mortality/MorbidityMuch of what is known about the morbidity and mortality of PVS comes from the Natural History Study of Congenital Heart Defects and the Second Natural History Study of Congenital Heart Defects. The Natural History Study of Congenital Heart Defects included an initial cardiac catheterization and then follow-up for events over an 8-year period. The Second Natural History Study of Congenital Heart Defects reported on 16-27 years of follow up from the same cohort. The studies demonstrated that adverse outcomes directly relate to the right ventricular systolic pressure gradient.
SexThe male-to-female ratio is approximately 1:1. AgePVS most commonly presents in newborns. It can be asymptomatic for years. Please click here to view the full topic text: Pulmonic Valvular Stenosis |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |